{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:44:51Z","timestamp":1775155491800,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","award":["AbbVie"],"award-info":[{"award-number":["AbbVie"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and aim<\/jats:title>\n            <jats:p>The MY PD-CARE digital tool is intended to empower people with Parkinson\u2019s disease (PD) and care partners to actively identify and track changes in key symptoms of advancing PD and to facilitate discussions with healthcare professionals (HCPs). MY PD-CARE was adapted from MANAGE-PD, a validated, web-based tool that helps HCPs identify patients with inadequate symptom control. The SELF-AWARE (<jats:bold>\n                <jats:underline>S<\/jats:underline>\n              <\/jats:bold>tudy on <jats:bold>\n                <jats:underline>E<\/jats:underline>\n              <\/jats:bold>thnographic research and human factors eva<jats:bold>\n                <jats:underline>L<\/jats:underline>\n              <\/jats:bold>uation <jats:bold>\n                <jats:underline>F<\/jats:underline>\n              <\/jats:bold>or a tool to increase <jats:bold>\n                <jats:underline>AW<\/jats:underline>\n              <\/jats:bold>areness, self-<jats:bold>\n                <jats:underline>A<\/jats:underline>\n              <\/jats:bold>ssessment, and <jats:bold>\n                <jats:underline>R<\/jats:underline>\n              <\/jats:bold>eporting of PD pati<jats:bold>\n                <jats:underline>E<\/jats:underline>\n              <\/jats:bold>nts uncontrolled on oral medication) study investigated MY PD-CARE ease of use, understandability, and acceptance among people with PD and their care partners.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>SELF-AWARE was a non-interventional, cross-sectional, observational study. Participants (patients\/care partners) assessed MY PD-CARE during 1-time virtual interviews conducted by trained medical anthropologists using qualitative ethnographic and human factor evaluation methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In 90.7% of interviews (43 patients; 31 care partners), \u2265\u20091 patient\/care partner participant was comfortable with technology. Most participants understood the purpose\/objective of MY PD-CARE and agreed it was simple and easy to use. Although the medical terminology was not fully self-explanatory to many participants, half found the glossary helpful. Approximately 60% indicated MY PD-CARE could have more value with free-text input. Participants agreed that MY PD-CARE is useful for tracking symptoms and encouraging discussions with HCPs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>People with PD and their care partners perceived MY PD-CARE as useful and acceptable for tracking and increasing awareness of symptoms and facilitating discussions with HCPs. Participant feedback helped optimize the updated design of this digital tool.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10072-025-08342-0","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:32:01Z","timestamp":1752816721000},"page":"5061-5071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ethnographic evaluation of usability, understandability, and acceptance of the MY PD-CARE digital tool to facilitate Parkinson\u2019s disease symptom tracking and patients\u2019 and care partners\u2019 communications with the treating healthcare professional: the SELF-AWARE study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-2807","authenticated-orcid":false,"given":"Angelo","family":"Antonini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5171-1166","authenticated-orcid":false,"given":"Tove","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Hursey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0756-7478","authenticated-orcid":false,"given":"Per","family":"Odin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"4","key":"8342_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7861\/clinmed.2020-0220","volume":"20","author":"C Kobylecki","year":"2020","unstructured":"Kobylecki C (2020) Update of the diagnosis and management of Parkinson\u2019s disease. Clin Med 20(4):393\u2013398. https:\/\/doi.org\/10.7861\/clinmed.2020-0220","journal-title":"Clin Med"},{"issue":"8","key":"8342_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.91","volume":"18","author":"A Schapira","year":"2017","unstructured":"Schapira A, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev 18(8):435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.91","journal-title":"Nat Rev"},{"key":"8342_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.parkreldis.2019.05.009","volume":"65","author":"GD Kuhlman","year":"2019","unstructured":"Kuhlman GD, Flanigan JL, Sperling SA et al (2019) Predictors of health-related quality of life in Parkinson\u2019s disease. Parkinsonism Relat Disord 65:86\u201390. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.009","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"8342_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/PL00007856","volume":"249","author":"T Foltynie","year":"2002","unstructured":"Foltynie T, Brayne C, Barker RA (2002) The heterogeneity of idiopathic Parkinson\u2019s disease. J Neurol 249(2):138\u2013145. https:\/\/doi.org\/10.1007\/PL00007856","journal-title":"J Neurol"},{"issue":"1","key":"8342_CR5","doi-asserted-by":"publisher","first-page":"e33989","DOI":"10.7759\/cureus.33989","volume":"15","author":"N Al-Khammash","year":"2023","unstructured":"Al-Khammash N, Al-Jabri N, Albishi A et al (2023) Quality of life in patients with Parkinson\u2019s disease: a cross-sectional study. Cureus 15(1):e33989. https:\/\/doi.org\/10.7759\/cureus.33989","journal-title":"Cureus"},{"key":"8342_CR6","doi-asserted-by":"publisher","DOI":"10.31478\/201209d","author":"C Alston","year":"2012","unstructured":"Alston C, Paget L, Halvorson GC et al (2012) Communicating with patients on health care evidence. NAM Perspect. https:\/\/doi.org\/10.31478\/201209d","journal-title":"NAM Perspect"},{"issue":"1","key":"8342_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/JPD-181431","volume":"9","author":"FP Vlaanderen","year":"2019","unstructured":"Vlaanderen FP, Rompen L, Munneke M et al (2019) The voice of the Parkinson customer. J Parkinsons Dis 9(1):197\u2013201. https:\/\/doi.org\/10.3233\/JPD-181431","journal-title":"J Parkinsons Dis"},{"key":"8342_CR8","doi-asserted-by":"publisher","first-page":"1150634","DOI":"10.3389\/fneur.2023.1150634","volume":"14","author":"LJW Evers","year":"2023","unstructured":"Evers LJW, Peeters JM, Bloem BR et al (2023) Need for personalized monitoring of Parkinson\u2019s disease: the perspectives of patients and specialized healthcare providers. Front Neurol 14:1150634. https:\/\/doi.org\/10.3389\/fneur.2023.1150634","journal-title":"Front Neurol"},{"issue":"s1","key":"8342_CR9","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3233\/JPD-202408","volume":"11","author":"S Riggare","year":"2021","unstructured":"Riggare S, Stamford J, H\u00e4gglund M (2021) A long way to go: patient perspectives on digital health for Parkinson\u2019s disease. J Parkinsons Dis 11(s1):S5\u2013S10. https:\/\/doi.org\/10.3233\/JPD-202408","journal-title":"J Parkinsons Dis"},{"key":"8342_CR10","doi-asserted-by":"publisher","first-page":"1203945","DOI":"10.3389\/fdgth.2023.1203945","volume":"5","author":"H Mumtaz","year":"2023","unstructured":"Mumtaz H, Riaz MH, Wajid H et al (2023) Current challenges and potential solutions to the use of digital health technologies in evidence generation: a narrative review. Front Digit Health 5:1203945. https:\/\/doi.org\/10.3389\/fdgth.2023.1203945","journal-title":"Front Digit Health"},{"key":"8342_CR11","doi-asserted-by":"publisher","first-page":"958571","DOI":"10.3389\/fmedt.2022.958571","volume":"4","author":"RH Barony Sanchez","year":"2022","unstructured":"Barony Sanchez RH, Bergeron-Drolet LA, Sasseville M et al (2022) Engaging patients and citizens in digital health technology development through the virtual space. Front Med Technol 4:958571. https:\/\/doi.org\/10.3389\/fmedt.2022.958571","journal-title":"Front Med Technol"},{"key":"8342_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.parkreldis.2021.10.009","volume":"92","author":"A Antonini","year":"2021","unstructured":"Antonini A, Odin P, Schmidt P et al (2021) Validation and clinical value of the MANAGE-PD tool: a clinician-reported tool to identify Parkinson\u2019s disease patients inadequately controlled on oral medications. Parkinsonism Relat Disord 92:59\u201366. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.10.009","journal-title":"Parkinsonism Relat Disord"},{"key":"8342_CR13","unstructured":"EU MANAGE-PD tool (ABBV-AA-00120-MC V1.1) (2023) https:\/\/www.managepd.eu\/ (accessed 17 April 2024)."},{"key":"8342_CR14","unstructured":"US MANAGE-PD tool (ABBV-US-00084-MC, V2) (2021) https:\/\/www.managepd.com\/ (accessed 17 April 2024)."},{"key":"8342_CR15","unstructured":"EU MY PD-CARE tool (BE-00128-MC) (2023) https:\/\/www.mypdcare.eu\/ (accessed April 17, 2024)"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08342-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08342-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08342-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T03:10:07Z","timestamp":1759288207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08342-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["8342"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08342-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated to correct the identified errros, most notably around the naming of the MY PD-CARE tool and figure quality.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles originating in the European Medicines Agency Module XVI Guideline on Good Pharmacovigilance Practices. The study was approved by an independent ethics committee as required by local laws and regulations. All study participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"AA has received compensation for consultancy and speaker-related activities from AbbVie, Bial, Boehringer Ingelheim, Britannia, Ever Pharma, General Electric, Jazz Pharmaceuticals, Kyowa Kirin, Medscape, Neuroderm, Roche, Theravance Biopharma, UCB, and Zambon; has received research support from Angelini Pharmaceuticals, Bial, Cariparo Foundation, Horizon 2020 Grant 825785, Horizon2020 Grant 101016902, Lundbeck, Ministry of Education University and Research (MIUR), Movement Disorders Society, and Roche; and reports consultancy services for Boehringer Ingelheim for legal cases on pathological gambling. TH has received speaker honoraria from AbbVie, Britannia, Convatec, Ever Pharma, Lundbeck, Neuroderm, and Nordic Infucare; serves as a principal investigator for a study sponsored by AbbVie; and serves on the data monitoring committee for a study sponsored by Lundbeck. AH has no conflict of interest to disclose. LB and JCP are full-time employees of AbbVie and may hold AbbVie stock and\/or stock options. PO has received compensation for consultancy and speaker-related activities from AbbVie, Bial, Britannia, Ever Pharma, Nordic Infucare, Stada, and Zambon, and has received royalties from Uni-Med Verlag. The authors have no other relevant financial or non-financial interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}